Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 6.97% |
| Q2 2025 | 5.09% |
| Q1 2025 | -5.91% |
| Q4 2024 | 11.61% |
| Q3 2024 | -5.59% |
| Q2 2024 | 6.35% |
| Q1 2024 | 4.84% |
| Q4 2023 | 16.63% |
| Q3 2023 | -15.72% |
| Q2 2023 | -26.31% |
| Q1 2023 | -3.08% |
| Q4 2022 | -1.28% |
| Q3 2022 | 1.44% |
| Q2 2022 | 6.97% |
| Q1 2022 | -11.51% |
| Q4 2021 | -2.96% |
| Q3 2021 | 3.23% |
| Q2 2021 | 8.35% |
| Q1 2021 | -7.37% |
| Q4 2020 | 12.18% |
| Q3 2020 | -3.05% |
| Q2 2020 | 7.25% |
| Q1 2020 | -4.81% |
| Q4 2019 | 2.43% |
| Q3 2019 | 0.72% |
| Q2 2019 | 23.78% |
| Q1 2019 | -10.05% |
| Q4 2018 | 7.95% |
| Q3 2018 | 3.77% |
| Q2 2018 | 8.62% |
| Q1 2018 | -1.54% |
| Q4 2017 | 7.11% |
| Q3 2017 | -1.71% |
| Q2 2017 | 12.40% |
| Q1 2017 | -2.17% |
| Q4 2016 | -0.62% |
| Q3 2016 | 6.81% |
| Q2 2016 | 8.32% |
| Q1 2016 | 4.44% |
| Q4 2015 | 12.37% |